Overcoming bottlenecks to accelerate IND readiness
18 Sep 2025
Gene Therapy CMC & Process Development
- Addressing the persistent challenge of vector productivity and variability in AAV and LVV manufacturing
- Aligning analytical methods and release assays with evolving global regulatory expectations
- Tackling delays in tech transfer and CMC documentation that slow IND submissions
- Discussing how emerging approaches (platforms, partnerships, and process innovations) are reshaping timelines and quality outcomes
Industry Expert
